Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duarte

Showing results (791-800 of 824) with videos related to

Pageof 83
Sort By:
Pathogens (Basel, Switzerland)|February 25, 2023
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with <i>Leishmania amazonensis</i>Tauane G Soyer, Fernanda F Ramos, Isabela A G Pereira, et al.
Cellular Immunology|October 6, 2018
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individualsMariana P Lima, Lourena E Costa, Daniela P Lage, et al.
Parasitology International|October 20, 2018
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infectionGrasiele S V Tavares, Débora V C Mendonça, Carolina K Miyazaki, et al.
Plos Neglected Tropical Diseases|April 11, 2013
Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
BMC Genomics|March 16, 2007
Signal transduction-related responses to phytohormones and environmental challenges in sugarcaneFlávia R Rocha, Flávia S Papini-Terzi, Milton Y Nishiyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic<sup>®</sup> F127-based polymeric micelle system against Leishmania amazonensis infectionDébora V C Mendonça, Grasiele S V Tavares, Daniela P Lage, et al.
Acta Reumatologica Portuguesa|March 31, 2018
Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 updateA M Rodrigues, H Canhão, A Marques, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Pageof 83

Showing results (791-800 of 824) with videos related to

Sort By:
Pageof 83
Pathogens (Basel, Switzerland)|February 25, 2023
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with <i>Leishmania amazonensis</i>Tauane G Soyer, Fernanda F Ramos, Isabela A G Pereira, et al.
Cellular Immunology|October 6, 2018
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individualsMariana P Lima, Lourena E Costa, Daniela P Lage, et al.
Parasitology International|October 20, 2018
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infectionGrasiele S V Tavares, Débora V C Mendonça, Carolina K Miyazaki, et al.
Plos Neglected Tropical Diseases|April 11, 2013
Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasisVivian T Martins, Miguel A Chávez-Fumagalli, Lourena E Costa, et al.
BMC Genomics|March 16, 2007
Signal transduction-related responses to phytohormones and environmental challenges in sugarcaneFlávia R Rocha, Flávia S Papini-Terzi, Milton Y Nishiyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 16, 2018
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic<sup>®</sup> F127-based polymeric micelle system against Leishmania amazonensis infectionDébora V C Mendonça, Grasiele S V Tavares, Daniela P Lage, et al.
Acta Reumatologica Portuguesa|March 31, 2018
Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 updateA M Rodrigues, H Canhão, A Marques, et al.
Parasitology Research|September 28, 2023
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasisMarcelo M Jesus, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Pageof 83